GE HealthCare Technologies Inc. Common Stock(GEHC)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $58.75 – $89.77
- YTD
- -21.52%
- IV Rank (30D)
- 14.21
- Straddle Price
- $4.80
- P/C Vol Ratio
- 0.15
- Market Cap
- $29.6B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.53% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 10.03% (VRP-adj) |
| WACC | 8.17% |
| Volatility Risk Premium | +15.7pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 23.4% |
| Rev. Growth (YoY, DCF input) | +2.5% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.02 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $1.5B |
| Return on Equity (TTM) | 17.9% |
| Book / Price | 36.2% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 39.1% |
| FCF Margin (TTM) | 7.2% |
| Debt / Equity | 0.95 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +7.7% (reverse-DCF on current price) |
| SMA 50 | $66.20 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $63.34 |
| Bollinger Width / SMA20 | 13.2% (drives anchor stability) |
| Net Debt | $7.8B |
| Market Cap | $30B |
| Horizon | Expected α | z Pred | Blended z | Rank % | Active? |
|---|---|---|---|---|---|
| 21d | -0.4% ⚠ | +0.78 | +0.74 | 67.5% | — |
| 42d | -1.6% ⚠ | +0.68 | +0.69 | 62.8% | — |
| 63d | -3.1% ⚠ | +0.30 | +0.50 | 54.7% | — |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $42.59 | 20% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $147.65 | 9% | median 34.5× · 5 peers |
| Peer EV/EBITDA | $186.40 | 9% | median 25.2× · 6 peers |
| Peer P/B | $211.38 | 2% | median 9.1× · 8 peers |
| Peer P/S | $230.73 | 6% | median 4.9× · 8 peers |
| Market Anchor (SMA50) | $66.20 | 34% | stability 84% (BB-width) |
| Options Expected (B-L 30d) | $62.16 | 20% | 24 strikes · skew -1.10 |
- Industry (SIC)
- X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS (3844)
- Exchange
- XNAS
- Market Cap
- $29.6B
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical d…
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +8.04% | 4 |
| Feb | +10.80% | 4 |
| Mar | -3.37% | 4 |
| Apr | -5.55% | 4 |
| May | +0.41% | 4 |
| Jun | +3.69% | 4 |
| Jul | +4.48% | 3 |
| Aug | -3.35% | 3 |
| Sep | +3.73% | 3 |
| Oct | -4.71% | 3 |
| Nov | +0.56% | 3 |
| Dec | +3.92% | 3 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-07-31 | Pre-Market | 8.07% | 1.95% | 0.24x | Within |
| 2024-10-30 | Pre-Market | 6.20% | 2.53% | 0.41x | Within |
| 2025-02-13 | Pre-Market | 6.35% | 8.56% | 1.35x | Exceeded |
| 2025-04-30 | Pre-Market | 7.27% | 3.44% | 0.47x | Within |
| 2025-07-30 | Pre-Market | 8.17% | 8.13% | 1.00x | Within |
| 2025-10-29 | Pre-Market | 5.70% | 2.54% | 0.45x | Within |
| 2026-02-04 | Pre-Market | 5.26% | 4.84% | 0.92x | Within |
| 2026-04-29 | Pre-Market | 6.20% | 12.93% | 2.09x | Exceeded |
- IV Rank (30D)
- 14.21
- IV Rank (7D)
- 100
- Avg IV
- 41.5%
- Straddle (30D)
- $4.80
- Straddle (7D)
- $2.25
- P/C Volume
- 0.15
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 1.18
- Correlation (SPY)
- 45.2%
- R²
- 0.20
- Ann. Volatility
- 32.3%
- SPY Volatility
- 12.3%
Above average volatility - stock moves with market amplification
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC Custodian | $69.14M | 37.07% | 2026-03-31 |
| 2 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $36.67M | 19.66% | 2026-03-31 |
| 3 | JANE STREET GROUP, LLC Custodian | $25.43M | 13.63% | 2026-03-31 |
| 4 | WOLVERINE TRADING, LLC Custodian | $11.52M | 6.18% | 2025-09-30 |
| 5 | PEAK6 LLC | $10.79M | 5.79% | 2026-03-31 |
| 6 | Walleye Trading LLC | $7.35M | 3.94% | 2026-03-31 |
| 7 | Twin Tree Management, LP | $4.40M | 2.36% | 2026-03-31 |
| 8 | Squarepoint Ops LLC | $2.69M | 1.44% | 2026-03-31 |
| 9 | Walleye Capital LLC | $2.56M | 1.37% | 2026-03-31 |
| 10 | MILLENNIUM MANAGEMENT LLC Custodian | $2.54M | 1.36% | 2026-03-31 |
| 11 | CITIGROUP INC Custodian | $2.42M | 1.30% | 2026-03-31 |
| 12 | TUDOR INVESTMENT CORP ET AL | $1.90M | 1.02% | 2026-03-31 |
| 13 | Cubist Systematic Strategies, LLC | $1.87M | 1.00% | 2025-09-30 |
| 14 | CAPITAL FUND MANAGEMENT S.A. | $1.74M | 0.94% | 2026-03-31 |
| 15 | Point72 Asset Management, L.P. | $1.17M | 0.63% | 2026-03-31 |
| 16 | Parallax Volatility Advisers, L.P. | $722.60K | 0.39% | 2026-03-31 |
| 17 | D. E. Shaw & Co., Inc. Custodian | $711.80K | 0.38% | 2026-03-31 |
| 18 | Volterra Technologies LP | $612.15K | 0.33% | 2026-03-31 |
| 19 | GOLDMAN SACHS GROUP INC Custodian | $540.97K | 0.29% | 2026-03-31 |
| 20 | BNP PARIBAS FINANCIAL MARKETS Custodian | $533.85K | 0.29% | 2026-03-31 |
| 21 | Alphadyne Asset Management LP | $412.84K | 0.22% | 2026-03-31 |
| 22 | CAPSTONE INVESTMENT ADVISORS, LLC | $384.37K | 0.21% | 2026-03-31 |
| 23 | TWO SIGMA INVESTMENTS, LP | $355.90K | 0.19% | 2026-03-31 |
| 24 | UBS Group AG Custodian | $28.47K | 0.02% | 2026-03-31 |
| 25 | Capula Management Ltd | $21.35K | 0.01% | 2026-03-31 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC Custodian | $55.52M | 29.02% | 2026-03-31 |
| 2 | Temasek Holdings (Private) Ltd | $45.33M | 23.69% | 2026-03-31 |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $24.27M | 12.68% | 2026-03-31 |
| 4 | MILLENNIUM MANAGEMENT LLC Custodian | $10.75M | 5.62% | 2026-03-31 |
| 5 | PEAK6 LLC | $9.62M | 5.03% | 2026-03-31 |
| 6 | CITIGROUP INC Custodian | $7.26M | 3.79% | 2026-03-31 |
| 7 | Walleye Trading LLC | $5.93M | 3.10% | 2026-03-31 |
| 8 | WOLVERINE TRADING, LLC Custodian | $5.05M | 2.64% | 2025-09-30 |
| 9 | Cubist Systematic Strategies, LLC | $3.65M | 1.91% | 2025-09-30 |
| 10 | GOLDMAN SACHS GROUP INC Custodian | $3.56M | 1.86% | 2026-03-31 |
| 11 | JANE STREET GROUP, LLC Custodian | $3.47M | 1.81% | 2026-03-31 |
| 12 | CAPSTONE INVESTMENT ADVISORS, LLC | $3.32M | 1.73% | 2026-03-31 |
| 13 | Squarepoint Ops LLC | $2.55M | 1.33% | 2026-03-31 |
| 14 | UBS Group AG Custodian | $2.07M | 1.08% | 2026-03-31 |
| 15 | Eisler Capital Management Ltd. | $1.88M | 0.98% | 2025-09-30 |
| 16 | Point72 Asset Management, L.P. | $1.32M | 0.69% | 2026-03-31 |
| 17 | TUDOR INVESTMENT CORP ET AL | $1.28M | 0.67% | 2026-03-31 |
| 18 | CAPITAL FUND MANAGEMENT S.A. | $1.21M | 0.63% | 2026-03-31 |
| 19 | Walleye Capital LLC | $1.21M | 0.63% | 2026-03-31 |
| 20 | BNP PARIBAS FINANCIAL MARKETS Custodian | $1.07M | 0.56% | 2026-03-31 |
| 21 | Alphadyne Asset Management LP | $911.10K | 0.48% | 2026-03-31 |
| 22 | Capula Management Ltd | $135.24K | 0.07% | 2026-03-31 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Kevin Lobo | Director | Buy (P) | +10,000 | $64.18 | $641.8K | EDGAR |
| 2026-05-19 | Jeannette Bankes | CEO, Patient Care Solutions | Tax (F) | −5,535 | $62.67 | -$346.9K | EDGAR |
| 2026-05-19 | Philip Rackliffe | CEO, AIS | Award (A) | +16,458 | — | EDGAR | |
| 2026-05-13 | Rodney F Hochman | Director | Buy (P) | +1,618 | $62.03 | $100.4K | EDGAR |
| 2026-05-11 | William J Stromberg | Director | Award (A) | +3,586 | — | EDGAR | |
| 2026-05-11 | Anne T Madden | Director | Award (A) | +5,868 | — | EDGAR | |
| 2026-05-11 | Kevin Lobo | Director | Award (A) | +3,586 | — | EDGAR | |
| 2026-05-11 | CATHERINE A LESJAK | Director | Award (A) | +3,586 | — | EDGAR | |
| 2026-05-11 | Rodney F Hochman | Director | Award (A) | +6,275 | — | EDGAR | |
| 2026-05-11 | H LAWRENCE JR CULP | Director | Award (A) | +7,743 | — | EDGAR | |
| 2026-05-11 | Watkin Phoebe L. Yang | Director | Mixed | +4,586 | $63.01 | $63.0K | EDGAR |
| 2026-05-07 | William J Stromberg | Director | Buy (P) | +1,000 | $61.69 | $61.7K | EDGAR |
| 2026-05-07 | H LAWRENCE JR CULP | Director | Buy (P) | +80,805 | $61.88 | $5.00M | EDGAR |
| 2026-05-01 | JAMES SACCARO | Chief Financial Officer | Buy (P) | +3,310 | $60.60 | $200.6K | EDGAR |
| 2026-04-30 | Peter J Arduini | President and CEO | Buy (P) | +4,169 | $59.92 | $249.8K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | ELECTRIC CO GENERAL | 10%+ Owner | 32,631,302 | $2.13B | $0 | 11 | 2024-03-15 |
| 2 | H LAWRENCE JR CULP | Director | 344,553 | $22.46M | $5.05M | 9 | 2026-05-11 |
| 3 | Peter J Arduini | President and CEO | 259,424 | $16.91M | $249.8K | 13 | 2026-04-30 |
| 4 | Frank R Jimenez | GC & Corporate Secretary | 93,932 | $6.12M | $206.4K | 13 | 2026-04-30 |
| 5 | Taha Kass-Hout | Chief Technology Officer | 92,909 | $6.06M | -$259.7K | 13 | 2026-03-04 |
| 6 | JAMES SACCARO | Chief Financial Officer | 87,471 | $5.70M | $200.6K | 12 | 2026-05-01 |
| 7 | Helmut Zodl | Chief Financial Officer | 66,887 | $4.36M | $0 | 4 | 2023-12-29 |
| 8 | Jan Makela | CEO, Imaging | 63,348 | $4.13M | -$12.60M | 8 | 2024-05-15 |
| 9 | Betty D Larson | Chief People Officer | 54,459 | $3.55M | $0 | 3 | 2024-03-05 |
| 10 | Philip Rackliffe | CEO, AIS | 43,187 | $2.81M | -$78.9K | 10 | 2026-05-19 |
| 11 | Roland Rott | CEO, Imaging | 41,082 | $2.68M | -$500.7K | 20 | 2026-03-04 |
| 12 | Kenneth R. Stacherski | Chief Enterprise Oper. Officer | 40,996 | $2.67M | -$1.58M | 11 | 2025-09-03 |
| 13 | Jeannette Bankes | CEO, Patient Care Solutions | 38,357 | $2.50M | $0 | 3 | 2026-05-19 |
| 14 | Kevin Michael O'Neill | CEO, PDx | 32,803 | $2.14M | -$1.21M | 13 | 2026-03-04 |
| 15 | Adam Y Holton | Chief People Officer | 22,225 | $1.45M | $0 | 4 | 2026-03-04 |
| 16 | Rodney F Hochman | Director | 21,504 | $1.40M | $100.4K | 5 | 2026-05-13 |
| 17 | Anne T Madden | Director | 19,479 | $1.27M | $0 | 4 | 2026-05-11 |
| 18 | William J Stromberg | Director | 18,916 | $1.23M | $61.7K | 5 | 2026-05-11 |
| 19 | Thomas J. Westrick | CEO, Patient Care Solutions | 18,501 | $1.21M | -$222.1K | 8 | 2025-03-05 |
| 20 | Kevin Lobo | Director | 14,363 | $936.2K | $641.8K | 3 | 2026-05-26 |
| 21 | Watkin Phoebe L. Yang | Director | 13,702 | $893.1K | $63.0K | 4 | 2026-05-11 |
| 22 | CATHERINE A LESJAK | Director | 12,702 | $827.9K | $0 | 4 | 2026-05-11 |
| 23 | George A. Newcomb | Chief Accounting Officer | 10,639 | $693.5K | -$185.1K | 11 | 2026-03-04 |
| 24 | RISA J LAVIZZO-MOUREY | Director | 10,157 | $662.0K | $0 | 3 | 2025-05-30 |
| 25 | LLOYD JR HOWELL | Director | 9,116 | $594.2K | $0 | 3 | 2025-05-30 |
| 26 | Tomislav Mihaljevic | Director | 9,116 | $594.2K | $0 | 3 | 2025-05-30 |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-11 | 0001932393-26-000034 | EDGAR |
| 2026-04-29 | 0001932393-26-000030 | EDGAR |
| 2026-03-17 | 0001932393-26-000013 | EDGAR |
| 2026-02-27 | 0001932393-26-000010 | EDGAR |
| 2026-02-04 | 0001932393-26-000006 | EDGAR |
| 2025-12-15 | 0001193125-25-319383 | EDGAR |
| 2025-12-02 | 0001193125-25-305400 | EDGAR |
| 2025-10-29 | 0001932393-25-000052 | EDGAR |
| 2025-07-30 | 0001932393-25-000048 | EDGAR |
| 2025-07-24 | 0001932393-25-000044 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-29 | 0001932393-26-000031 | EDGAR |
| 2025-10-29 | 0001932393-25-000053 | EDGAR |
| 2025-07-30 | 0001932393-25-000049 | EDGAR |
| 2025-04-30 | 0001932393-25-000014 | EDGAR |
| 2024-10-30 | 0001932393-24-000050 | EDGAR |
| 2024-07-31 | 0001932393-24-000044 | EDGAR |
| 2024-04-30 | 0001932393-24-000034 | EDGAR |
| 2023-10-31 | 0001932393-23-000125 | EDGAR |
| 2023-07-25 | 0001932393-23-000112 | EDGAR |
| 2023-04-25 | 0001932393-23-000087 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 15.6 |
| P/B Ratio | 2.8 |
| P/S Ratio | 1.4 |
| EV/EBITDA | 10.3 |
| TTM Revenue | $21.0B |
| TTM Net Income | $1.9B |
| TTM EPS | $4.18 |
| ROE | 17.9% |
| Dividend Yield | 0.22% |
| Debt/Equity | 0.95 |